Reagents. The Pt(IV) compounds OxPt(Succ)(OAc), OxPt(Succ) 2 , CisPt(Succ)(OAc) (Succ = 2-(2,5-dioxopyrrolidin-1-yl)ethylcarbamato) were synthesized at the Institute of Inorganic Chemistry, University of Vienna according to protocols published by Pichler et al. and Mayr et al. 19, 34 Satraplatin was purchased from Boc Science (New York, USA). Ammonium formate (trace metal basis) was obtained from Sigma Aldrich (Steinheim, Germany). Acetonitrile (hypergrade for LC-MS), nitric acid (suprapure, 65%) and the platinum ICP standard (1 g/L) were purchased from Merck (Darmstadt, Germany). The platinum standard solution enriched with 194 Pt (0.02% 192 Pt, 97.08% 194 Pt, 2.04% 195 Pt, 0.72% 196 Pt, and 0.14% 198 Pt) was diluted from base material from Isoflex (San Francisco, USA). Water for sample preparation and HPLC was purified using an Aquatron A4000D system (Barloworld Scientific, Nemour, France). Prior to application, all solutions were degassed using ultrasonication.
Electrochemical Reduction. Electrochemical reduction was performed using an electrochemical thin-layer cell (FlexCell, Antec Scientific, Zoeterwoude, The Netherlands) equipped with titanium as cathode material. The anode consisted of graphite-doped Teflon and for potential stabilization a reference electrode made of Pd/H 2 was used. A potential ramp (10 mV/s) from 0 to -3.0 V was applied to the cell to record mass voltammograms. Pt(IV) solutions (10 µmol/L) were prepared in solutions of 10 mmol/L ammonium formate (NH 4 FA; adjusted to pH 7.4 using ammonia) and acetonitrile (ACN) (50,50, v/v) and were continuously pumped through the cell using a flow rate of 10 µL/min delivered by a syringe pump (Model 74900, Cole Parmer, Vernon Hills, IL, USA). The cell effluent was subsequently introduced into an Orbitrap-based high-resolution MS (Exactive, Thermo Fisher Scientific, Bremen, Germany) operated in the positive electrospray ionization mode.
Detailed MS parameters are listed in Table S1 . Data processing was carried out using the software XCalibur 2.1 (Thermo Fisher Scientific) and OriginPro 2016 (OriginLab, Northhampton, MA, USA). Chromatographic separation. Separation of Pt(IV) prodrugs and their reduction products was performed by implementing an HPLC system (Shimadzu, Kyoto, Japan) between the electrochemical cell and an ESI-MS (Exactive) or an ICP-MS (iCAP Qc, Thermo Fisher Scientific, Bremen, Germany), respectively. The HPLC system comprised two LC-10ADVP pumps, a SIL-10A
autosampler, a SCL-10AVP system controller, a DGC-14A degasser and a CTO-10ASVP column oven. System control was performed using the software LCSolution 1.2.2 (Shimadzu). Detailed MS parameters are listed in Tables S2 and S3 . Reduction of the Pt(IV) compounds (10 µmol/L for LC-ESI-MS analysis, and 5 µmol/L for LC-ICP-MS analysis) was carried out at a constant potential of -3.0 V. The effluent of the cell was collected in an injection loop of a six-port valve (Rheodyne IDEX Health Science, Oak Habor, WA, USA) and transferred onto a polar-embedded C18-based column (ProntoSIL C18 ace-EPS, 100 x 2.0 mm, 3 µm, Bischoff Chromatography, Leonberg, Germany) by switching the valve. Gradient elution was applied using the gradient profile shown in Table S4 and ammonium formate (10 mM, pH 7.4) as eluent A and acetonitrile as eluent B at a flow rate of 300 µL/min. 
Quantification by means of EC-LC-IDA-ICP-MS. Species unspecific quantification was carried out by means of isotope dilution analysis (IDA)
.
